Thursday 29 October 2015

First day at EADO

EADO overview of last four years achievements in immunotherapy: ipilimumab, nivolumab and pembrolizumab. Good to see again the confirmation of their efficacy in melanoma.
(to be continued)




Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)